A specialty Pharmaceutical / Biotechnology company specializing in first in class and best in class topical drug delivery systems. Primary focus is on the discovery, development, and commercialization of products for the topical treatment of inflammatory and infectious diseases. To date, their drug discovery and development efforts have generated a robust product pipeline, including one New Drug Application {"NDA") and two others in Phase II clinical trials. They have another product in late pre-clinical development targeting actinic keratosis and have formulated numerous product candidates targeting digital ulcers, plaque psoriasis, "age-spots", excessive hair growth and skin infections utilizing a proprietary topical drug delivery technology.
View Top Employees from MediQuest Therapeutics, Inc.Website | http://www.mqti.com |
Revenue | $5 million |
Employees | 2 (0 on RocketReach) |
Founded | 2002 |
Address | 22322 20th Avenue Se S-100, Bothell, Washington 98021, US |
Phone | (425) 398-9580 |
Technologies |
JavaScript,
HTML,
G Suite
+6 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Health Care, Therapeutics |
Competitors | Biosyn , Inc., Biotie Therapies, Cytochroma Inc., Karus Therapeutics Limited, Poniard Pharmaceuticals , Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular MediQuest Therapeutics, Inc. employee's phone or email?
The MediQuest Therapeutics, Inc. annual revenue was $5 million in 2024.
MediQuest Therapeutics, Inc. is based in Bothell, Washington.
The NAICS codes for MediQuest Therapeutics, Inc. are [32541, 3254, 32, 325].
The SIC codes for MediQuest Therapeutics, Inc. are [283, 28].